Aviram Hochstadt

ORCID: 0000-0002-9404-3145
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Function and Risk Factors
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Ion channel regulation and function
  • ECG Monitoring and Analysis
  • Cardiac Imaging and Diagnostics
  • Cardiac Structural Anomalies and Repair
  • Infective Endocarditis Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Coronary Interventions and Diagnostics
  • Cardiovascular Effects of Exercise
  • COVID-19 Clinical Research Studies
  • Cardiac Arrest and Resuscitation
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Ultrasound in Clinical Applications
  • Acute Kidney Injury Research
  • Pulmonary Hypertension Research and Treatments
  • Long-Term Effects of COVID-19
  • Acute Myocardial Infarction Research
  • Hemodynamic Monitoring and Therapy
  • Heart Failure Treatment and Management
  • Mechanical Circulatory Support Devices
  • Pericarditis and Cardiac Tamponade

Tel Aviv University
2016-2025

Tel Aviv Sourasky Medical Center
2016-2024

Wolfson Medical Center
2011-2024

University Medical Center
2024

NYU Langone Health
2024

Holon Institute of Technology
2024

Mayo Clinic in Arizona
2022

Institute of Cardiology
2020

Institut du Thorax
2017

Inserm
2017

Information on the cardiac manifestations of coronavirus disease 2019 (COVID-19) is scarce. We performed a systematic and comprehensive echocardiographic evaluation consecutive patients hospitalized with COVID-19 infection.

10.1161/circulationaha.120.047971 article EN mit Circulation 2020-05-29

Data on the age at first arrhythmic event (AE) in Brugada syndrome are from limited patient cohorts. The aim of this study is 2-fold: (1) to define AE a large cohort patients with syndrome, and (2) assess influence mode documentation, sex, ethnicity AE.A survey 23 centers 10 Western 4 Asian countries gathered data 678 (91.3% men) documented time aborted cardiac arrest (group A, n=426) or after prophylactic implantable cardioverter-defibrillator implantation B, n=252). vast majority (94.2%)...

10.1161/circep.117.005222 article EN Circulation Arrhythmia and Electrophysiology 2017-12-01

Paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) is associated with increased morbidity and mortality. The effect of interventions to treat PVR the index TAVI was investigated.A registry consecutive patients who underwent intervention for ≥ moderate at 22 centers. principal outcomes were residual (AR) mortality 1 year treatment. A total 201 identified: 87 (43%) redo-TAVI, 79 (39%) plug closure, 35 (18%) balloon valvuloplasty. Median...

10.1093/eurheartj/ehad146 article EN European Heart Journal 2023-03-08

Background— The basic defect in long-QT syndrome type III (LQT3) is an excessive inflow of sodium current during phase 3 the action potential caused by mutations SCN5A gene. Most channel blockers reduce early (peak) and late components ( I Na NaL ), but ranolazine preferentially reduces . We, therefore, evaluated effects LQT3 D1790G mutation Methods Results— We performed experimental study TSA201 cells expressing mutation. then a long-term clinical evaluation patients carrying In study, was...

10.1161/circep.116.004370 article EN Circulation Arrhythmia and Electrophysiology 2016-10-01

Background: Polymorphic ventricular tachycardia (VT) without QT prolongation is well described in patients structural heart disease (mainly idiopathic fibrillation and Brugada syndrome) with acute ST-elevation myocardial infarction. Methods: Retrospective study of polymorphic VT related to coronary artery disease, but evidence ischemia. Results: The authors identified 43 whom developed within days an otherwise uncomplicated infarction or revascularization procedure. events were invariably...

10.1161/circulationaha.118.038036 article EN Circulation 2019-01-30

Background The scope of pericardial involvement in COVID-19 infection is unknown. We aimed to evaluate the prevalence, associates, and clinical impact hospitalized patients with COVID-19. Methods Results Consecutive underwent echocardiographic examination, irrespective indication, within 48 hours as part a prospective predefined protocol. Protocol included symptoms signs suggestive pericarditis, calculation modified early warning score, ECG assessment for effusion, left right ventricular...

10.1161/jaha.121.024363 article EN cc-by-nc-nd Journal of the American Heart Association 2022-03-21

Abstract Aims Indications for surgery in patients with degenerative mitral regurgitation (DMR) are increasingly liberal all clinical guidelines but the role of secondary outcome determinants (left atrial volume index ≥60 mL/m2, fibrillation, pulmonary artery systolic pressure ≥50 mmHg and moderate to severe tricuspid regurgitation) their impact on post-operative remain disputed. Whether these markers just reflective DMR severity or intrinsically affect survival after is uncertain may have...

10.1093/eurheartj/ehad004 article EN European Heart Journal 2023-01-26

Abstract Aims Asses the added value of quantitative evaluation tricuspid regurgitation (TR), proper cut-off for severe TR and ‘torrential TR’ based on outcome data. The TR, values associated with increased mortality are unknown. Methods results In patients all-cause assessed both qualitatively quantitatively by proximal iso-velocity surface area method, long-term 1-year analysis was conducted. Thresholds excess were using spline curves, receiver-operating characteristic minimum P-value...

10.1093/ehjci/jez267 article EN European Heart Journal - Cardiovascular Imaging 2019-10-12

Abstract Aims Distinctive types of polymorphic ventricular tachycardia (VT) respond differently to different forms therapy. We therefore performed the present study define electrocardiographic characteristics VT. Methods and results studied 190 patients for whom onset 305 VT events was available. The group included 87 with coronary artery disease who had spontaneous triggered by short-coupled extrasystoles in absence myocardial ischaemia. This 32 a long QT interval but nevertheless their...

10.1093/eurheartj/ehab138 article EN European Heart Journal 2021-02-18

We aim to assess changes in routine echocardiographic and longitudinal strain parameters patients recovering from Coronavirus disease 2019 during hospitalization at 3-month follow-up.Routine comprehensive echocardiography STE of both ventricles were performed for acute coronavirus (COVID-19) infection as part a prospective pre-designed protocol compared with ∼3 months after recovery 80 patients, using similar protocol. Significantly improved right ventricle (RV) fractional area change,...

10.1093/ehjci/jeab190 article EN European Heart Journal - Cardiovascular Imaging 2021-09-08

Background Information about the cardiac manifestations of Omicron variant COVID-19 is limited. We performed a systematic prospective echocardiographic evaluation consecutive patients hospitalized with infection and compared them similarly recruited were propensity matched wild-type variant. Methods Results A total 162 underwent complete within 24 hours admission propensity-matched (148 pairs). Echocardiography included left ventricular (LV) systolic diastolic, right (RV), strain,...

10.1161/jaha.122.027188 article EN cc-by-nc-nd Journal of the American Heart Association 2023-01-25

Abstract Aims Functional tricuspid regurgitation (FTR) associated with degenerative mitral (DMR) accentuates the severity of heart failure and is a marker poor prognosis. Little known about FTR asymptomatic DMR. Methods results The study included 1249 patients moderate or severe DMR from Mitral Regurgitation International Database‐Quantitative (MIDA‐Q) registry (mean age 64 ± 15 years, 25% female). Despite status, absent/trivial was noted in only 42%, mild 34.5%, 11%, 12.5%. Patients higher...

10.1002/ehf2.15278 article EN cc-by-nc-nd ESC Heart Failure 2025-03-23
Coming Soon ...